- Lobbying
- Lobbying by Boehringer Ingelhem Pharamaceuticals Inc
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Charles M. Clapton | Chief Health Counsel, House Energy/Com Chief Health Counsel, House Ways/Means Policy Advisor, Speaker D. Hastert Health Policy Dir., Senate HELP Cmte. Health Policy Dir, Senate HELP Cmte |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Registration
Issue(s) they said they’d lobby about: Compounding pharmacy legislation, drug safety, drug patents, federal health care spending..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate